Skip to main content
Log in

Excellent response to the clinical treatment of tophaceous gout

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Gout continues to be a health problem around the world, and the treatment may turn into a real challenge when the patient presents a certain degree of chronic renal failure (CRF). We discuss a case of tophaceous gout in a 68-year-old male patient without urolithiasis and with uric acid (UA) underexcretion and CRF (creatinine clearance of 42 ml/min). Uricosuric treatment with benzbromarone and urinary alkalinization was administered, and acute gouty attacks improved substantially. Subsequently, allopurinol was added to the treatment to accelerate tophi reduction in the hands, feet, elbows and knees. After 30 months of treatment, serum UA declined from 10 to 3.2 mg/dl. Urinary UA excretion of 0.44 g/24 h in the baseline rose to 0.85 g/24 h, returning to the baseline value after 30 months. UA clearance tripled, rising from 3.05 ml/min before treatment to 9.48 ml/min, and remained at this level. It is worth stressing that even in cases of severe tophaceous gout, the response to clinical treatment may be satisfactory with substantial reduction of tophi and full acute gouty attack remission even in patients presenting a certain degree of CRF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Kumar S, Gow P (2002) A survey of indications, results and complications of surgery for tophaceous gout. NZ Med J 115(1158):U109

    Google Scholar 

  2. Rott KT, Agudelo CA (2003) Gout. JAMA 289(21):2857–2860

    Article  PubMed  Google Scholar 

  3. Li EK (2004) Gout: a review of aetiology and treatment. Hong Kong Med J 10(4):261–270

    PubMed  CAS  Google Scholar 

  4. Kumar S, Ng J, Gow P (2005) Benzbromarone therapy in management of refractory gout. NZ Med J 1217(118):U1528

    Google Scholar 

  5. Parmar MS (2002) Chronic renal disease. BMJ 325:85–89

    Article  PubMed  Google Scholar 

  6. Terkeltaub RA (2003) Gout. N Engl J Med 349(17):1647–1655

    Article  PubMed  CAS  Google Scholar 

  7. Emmerson BT (2003) The management of gout. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Mosby, London, pp 1929–1936

    Google Scholar 

  8. Gyula P, Mila M (2003) History, classification and epidemiology of crystal-related arthropathies. In: Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH (eds) Rheumatology. Mosby, London, pp 1893–1901

    Google Scholar 

  9. Wortmann RL (2005) Recent advances in the management of gout and hyperuricemia. Curr Opin Rheumatol 17:319–324

    Article  PubMed  CAS  Google Scholar 

  10. Emmerson BT (1996) The management of gout. N Engl J Med 334(7):445–451

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cezar Augusto Muniz Caldas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caldas, C.A.M., Fuller, R. Excellent response to the clinical treatment of tophaceous gout. Clin Rheumatol 26, 1553–1555 (2007). https://doi.org/10.1007/s10067-006-0444-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-006-0444-6

Keywords

Navigation